Chen J H, Chuang S Y, Chen H J, et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study[J]. Arthritis Rheum, 2009, 61(2): 225.
Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels[J]. Nature, 2002, 417(6887): 447.
Unger S, Tausche A K, Kopprasch S, et al. Molecular basis of primary renal hyperuricemia: role of the human urate transporter hURAT1 [J]. Z Rheumatol, 2007, 66(7):556.
[17]
Uetake D, Ohno I, Ichida K, et al. Effect of fenofibrate on uric acid metabolism and urate transporter 1[J]. Intern Med, 2010, 49(2): 89.
[18]
Hamada T, Ichida K, Hosoyamada M, et al. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients[J]. Am J Hypertens, 2008, 21(10): 1157.
[19]
Lasko B, Sheedy B, Hingorani V, et al. RDEA594, a novel uricosuric agent, significantly reduced serum urate levels and was well tolerated in a phase 2 a pilot study in hyperuricemic gout patients [J]. Arthritis Rheum, 2009, 60: 413.
Wang C P, Wang X, Zhang X, et al. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice [J]. J Pharm Pharm Sci, 2010, 13(3): 411.
